CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- 8-K Event Results of operations · Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 4 Shares withheld for taxes Chief Science Officer gave up 32,862 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 17,540 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 18,929 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 8,115 shares (to pay taxes)
- 4 Shares withheld for taxes SVP Sales and Marketing gave up 5,428 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Legal Officer gave up 20,250 shares (to pay taxes)
- 4 Shares withheld for taxes See Remark gave up 14,305 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 83,305 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
Page 8 of 35 · 690 filings